---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-060316"
form_type: "8-K"
ticker: "BCYC"
cik: "0001761612"
company_name: "BICYCLE THERAPEUTICS PLC"
filed_at: "2025-06-17T23:59:59+00:00"
generated_at: "2026-05-19T04:50:58.524182+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Bicycle Therapeutics AGM results: all proposals pass, equity plan amendment sees 22.4% opposition

## Summary
- Re-elected director Alessandro Riva: 40.0M for, 9.1M against (18.5% opposed).
- Advisory 'say-on-pay' passed with 47.3M for, 1.7M against.
- Ratified PwC as US auditor: 49.1M for, 41K against.
- Approved amendment to 2020 Equity Incentive Plan: 38.1M for, 11.0M against (22.4% against).
- All ordinary resolutions, including re-appointment of UK auditors and adoption of 2024 accounts, passed.

## SEC filing metadata
- accession: 0001104659-25-060316
- form_type: 8-K
- ticker: BCYC
- cik: 0001761612
- company_name: BICYCLE THERAPEUTICS PLC
- filed_at: 2025-06-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1761612/000110465925060316/0001104659-25-060316-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1761612/000110465925060316/tm2518232d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-060316
- JSON: https://secwatch.observer/filing/0001104659-25-060316.json
- Plain text: https://secwatch.observer/filing/0001104659-25-060316.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.